Cargando…
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Cholangiocarcinoma (CCA) is a poorly treatable type of cancer and its incidence is dramatically increasing. The lack of understanding of the biology of this tumor has slowed down the identification of novel targets and the development of effective treatments. Based on next generation sequencing prof...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101358/ https://www.ncbi.nlm.nih.gov/pubmed/35563769 http://dx.doi.org/10.3390/cells11091463 |